News
Following an executive reset, the Tokyo firm hopes to grow its molecular and immunochemical testing businesses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback